Related Experiment Video
Updated: Jun 10, 2026
12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
[Neuromyelitis optica: a clinical update]
E Chiquete1, J Navarro-Bonnet, R Ayala-Armas
1Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Mexico.
Revista De Neurologia
|July 30, 2010
Summary
Neuromyelitis optica (NMO) is an autoimmune CNS disorder distinct from multiple sclerosis (MS). Discoveries like anti-aquaporin-4 antibodies aid NMO diagnosis, but effective treatments remain a challenge.
Area of Science:
- Neuroimmunology
- Central Nervous System Disorders
- Demyelinating Diseases
Context:
- Neuromyelitis optica (NMO), or Devic's disease, is a rare autoimmune disorder.
- It primarily affects the optic nerves and spinal cord.
- NMO was historically misclassified as a form of multiple sclerosis (MS).
Purpose:
- To provide an updated clinical overview of NMO.
- To discuss its nature, progression, diagnosis, and treatment.
- To highlight recent advancements in understanding NMO.
Summary:
- NMO is an autoimmune, inflammatory demyelinating disease of the CNS.
- Distinguishing NMO from MS is crucial due to differing immunopathology and treatment.
- The identification of anti-aquaporin-4 (AQP4) antibodies is a key diagnostic advancement.
Impact:
- Recent discoveries, particularly anti-AQP4 antibodies, have refined NMO diagnosis.
- NMO is now recognized as a distinct entity from MS.
- Despite diagnostic progress, NMO treatment remains a significant clinical challenge.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...